Clinical Trial Update: Renal Allograft Function and Histology Following Switching From A Tacrolimus to Sirolimus (SRL)-Based Immunosuppression- [Phase 3]

View source ↗

Summary

A Phase 3 trial in kidney transplant patients assessed renal allograft function and histology after switching from tacrolimus to sirolimus-based immunosuppressi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Prograf (Tacrolimus)
• Rapamune (sirolimus)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Kidney Transplant | Phase 3 | Status: TERMINATED | Results posted: 2017-06-07